U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C19H19N
Molecular Weight 261.3609
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PHENINDAMINE

SMILES

CN1CCC2=C(C1)C(C3=CC=CC=C23)C4=CC=CC=C4

InChI

InChIKey=ISFHAYSTHMVOJR-UHFFFAOYSA-N
InChI=1S/C19H19N/c1-20-12-11-16-15-9-5-6-10-17(15)19(18(16)13-20)14-7-3-2-4-8-14/h2-10,19H,11-13H2,1H3

HIDE SMILES / InChI

Molecular Formula C19H19N
Molecular Weight 261.3609
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/18907211

Phenindamine (thephorin or 2-methyl-9-phenyl-2,3,4,9-tetrahydro-1-pyridindene) a pyridindene derivative proved to be a potent antihistaminic. Phenindamine was used to treat sneezing; runny nose; itching, watery eyes; hives; rashes; itching; and other symptoms of allergies and the common cold.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
THEPHORIN

Approved Use

Phenindamine was used to treat sneezing; runny nose; itching, watery eyes; hives; rashes; itching; and other symptoms of allergies and the common cold.

Launch Date

-7.1634243E11
PubMed

PubMed

TitleDatePubMed
Thephorin in the treatment of disseminated neurodermatitis.
1948 Aug
The effects of phenindamine tartrate on sleepiness and psychomotor performance.
1992 Dec
Patents

Patents

Sample Use Guides

The maximum amount of phenindamine that you should take in 1 day is 75 mg.
Route of Administration: Other
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:07:13 UTC 2023
Edited
by admin
on Fri Dec 15 15:07:13 UTC 2023
Record UNII
772BQ8KSST
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PHENINDAMINE
INN   MI   VANDF   WHO-DD  
INN  
Official Name English
2-METHYL-9-PHENYL-2,3,4,9-TETRAHYDRO-1-PYRIDINDENE
Common Name English
PHENINDAMINE [MI]
Common Name English
2,3,4,9-TETRAHYDRO-2-METHYL-9-PHENYL-1H-INDENO(2,1-C)PYRIDINE
Systematic Name English
PHENINDAMINE [VANDF]
Common Name English
phenindamine [INN]
Common Name English
1,2,3,4-TETRAHYDRO-2-METHYL-9-PHENYL-2-AZAFLUORENE
Systematic Name English
NU-1504
Code English
THEPHORIN
Brand Name English
Phenindamine [WHO-DD]
Common Name English
1H-INDENO(2,1-C)PYRIDINE, 2,3,4,9-TETRAHYDRO-2-METHYL-9-PHENYL-
Systematic Name English
Classification Tree Code System Code
WHO-VATC QR06AX04
Created by admin on Fri Dec 15 15:07:13 UTC 2023 , Edited by admin on Fri Dec 15 15:07:13 UTC 2023
NCI_THESAURUS C29578
Created by admin on Fri Dec 15 15:07:13 UTC 2023 , Edited by admin on Fri Dec 15 15:07:13 UTC 2023
WHO-ATC R06AX04
Created by admin on Fri Dec 15 15:07:13 UTC 2023 , Edited by admin on Fri Dec 15 15:07:13 UTC 2023
Code System Code Type Description
NCI_THESAURUS
C87745
Created by admin on Fri Dec 15 15:07:13 UTC 2023 , Edited by admin on Fri Dec 15 15:07:13 UTC 2023
PRIMARY
ChEMBL
CHEMBL278398
Created by admin on Fri Dec 15 15:07:13 UTC 2023 , Edited by admin on Fri Dec 15 15:07:13 UTC 2023
PRIMARY
FDA UNII
772BQ8KSST
Created by admin on Fri Dec 15 15:07:13 UTC 2023 , Edited by admin on Fri Dec 15 15:07:13 UTC 2023
PRIMARY
INN
4170
Created by admin on Fri Dec 15 15:07:13 UTC 2023 , Edited by admin on Fri Dec 15 15:07:13 UTC 2023
PRIMARY
LACTMED
Phenindamine
Created by admin on Fri Dec 15 15:07:13 UTC 2023 , Edited by admin on Fri Dec 15 15:07:13 UTC 2023
PRIMARY
PUBCHEM
11291
Created by admin on Fri Dec 15 15:07:13 UTC 2023 , Edited by admin on Fri Dec 15 15:07:13 UTC 2023
PRIMARY
RXCUI
33283
Created by admin on Fri Dec 15 15:07:13 UTC 2023 , Edited by admin on Fri Dec 15 15:07:13 UTC 2023
PRIMARY RxNorm
WIKIPEDIA
PHENINDAMINE
Created by admin on Fri Dec 15 15:07:13 UTC 2023 , Edited by admin on Fri Dec 15 15:07:13 UTC 2023
PRIMARY
MERCK INDEX
m8617
Created by admin on Fri Dec 15 15:07:13 UTC 2023 , Edited by admin on Fri Dec 15 15:07:13 UTC 2023
PRIMARY Merck Index
DRUG BANK
DB01619
Created by admin on Fri Dec 15 15:07:13 UTC 2023 , Edited by admin on Fri Dec 15 15:07:13 UTC 2023
PRIMARY
MESH
C005430
Created by admin on Fri Dec 15 15:07:13 UTC 2023 , Edited by admin on Fri Dec 15 15:07:13 UTC 2023
PRIMARY
EPA CompTox
DTXSID0023452
Created by admin on Fri Dec 15 15:07:13 UTC 2023 , Edited by admin on Fri Dec 15 15:07:13 UTC 2023
PRIMARY
SMS_ID
100000082235
Created by admin on Fri Dec 15 15:07:13 UTC 2023 , Edited by admin on Fri Dec 15 15:07:13 UTC 2023
PRIMARY
EVMPD
SUB09764MIG
Created by admin on Fri Dec 15 15:07:13 UTC 2023 , Edited by admin on Fri Dec 15 15:07:13 UTC 2023
PRIMARY
CAS
82-88-2
Created by admin on Fri Dec 15 15:07:13 UTC 2023 , Edited by admin on Fri Dec 15 15:07:13 UTC 2023
PRIMARY
ECHA (EC/EINECS)
201-443-4
Created by admin on Fri Dec 15 15:07:13 UTC 2023 , Edited by admin on Fri Dec 15 15:07:13 UTC 2023
PRIMARY
DRUG CENTRAL
2129
Created by admin on Fri Dec 15 15:07:13 UTC 2023 , Edited by admin on Fri Dec 15 15:07:13 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY